Cell culture and xenograft studies were performed using genetically modified HCC tumor cells.<h4>Results</h4>As revealed by pubic RNA and protein database analysis and further western blotting quantification of clinical samples of HCC, SALL1 is decreased in human HCC. This evidence concerns the gene SALL1 and hepatocellular carcinoma.